Items where authors include "Steer, J."

Article

Sunderland, F., Sobey, A. orcid.org/0000-0001-6880-8338, Bramley, J. et al. (9 more authors) (2025) OpenLimbTT, a transtibial residual limb shape model for prosthetics simulation and design: creating a statistical anatomic model using sparse data. Data-Centric Engineering, 6. e39. ISSN 2632-6736

Shrikrishna, D. orcid.org/0009-0004-3663-4512, Steer, J., Bostock, B. et al. (9 more authors) (2025) Chronic obstructive pulmonary disease and the management of cardiopulmonary risk in the UK: a systematic literature review and modified delphi study. International Journal of Chronic Obstructive Pulmonary Disease, 20. pp. 2073-2090. ISSN 1176-9106

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Echevarria, C., Steer, J., Heslop-Marshall, K. et al. (9 more authors) (2017) The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax, 72 (8). pp. 686-693. ISSN 0040-6376

Echevarria, C., Steer, J., Heslop-Marshall, K. et al. (9 more authors) (2016) Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax, 71 (2). pp. 133-140. ISSN 0040-6376